Philadelphia Trust Company’s GSK GSK Stock Holding History

Philadelphia Trust Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.96M	Hold	53,688	–	–	0.21%	71
2025 Q4	$2.63M	Sell	53,688 -12,428	-19%	-$580K	0.18%	74
2025 Q3	$2.85M	Sell	66,116 -24	-0%	-$937	0.2%	70
2025 Q2	$2.54M	Sell	66,140 -644	-1%	-$24.6K	0.19%	72
2025 Q1	$2.59M	Sell	66,784 -120	-0.2%	-$4.39K	0.22%	73
2024 Q4	$2.26M	Sell	66,904 -1,941	-3%	-$69.9K	0.17%	82
2024 Q3	$2.81M	Sell	68,845 -3,317	-5%	-$136K	0.2%	76
2024 Q2	$2.78M	Sell	72,162 -460	-0.6%	-$19.4K	0.22%	75
2024 Q1	$3.11M	Buy	72,622 +2,600	+4%	+$107K	0.25%	70
2023 Q4	$2.6M	Sell	70,022 -1,000	-1%	-$35.9K	0.24%	77
2023 Q3	$2.58M	Sell	71,022 -120	-0.2%	-$4.26K	0.26%	78
2023 Q2	$2.54M	Sell	71,142 -120	-0.2%	-$4.3K	0.24%	86
2023 Q1	$2.54M	Sell	71,262 -300	-0.4%	-$10.5K	0.26%	84
2022 Q4	$2.52M	Sell	71,562 -150	-0.2%	-$5K	0.27%	84
2022 Q3	$2.11M	Buy	+71,712	New	+$2.72M	0.24%	77
2022 Q2	–	Sell	-73,153	Closed	-$3.98M	–	228
2022 Q1	$3.98M	Hold	73,153	–	–	0.31%	66
2021 Q4	$4.03M	Sell	73,153 -225	-0.3%	-$11.7K	0.29%	64
2021 Q3	$3.5M	Sell	73,378 -835	-1%	-$41.9K	0.26%	72
2021 Q2	$3.69M	Sell	74,213 -681	-0.9%	-$32.7K	0.25%	74
2021 Q1	$3.34M	Sell	74,894 -1,708	-2%	-$77.5K	0.26%	75
2020 Q4	$3.52M	Buy	76,602 +280	+0.4%	+$12.9K	0.29%	68
2020 Q3	$3.59M	Buy	76,322 +3,527	+5%	+$177K	0.35%	59
2020 Q2	$3.71M	Sell	72,795 -400	-0.5%	-$20.5K	0.39%	56
2020 Q1	$3.47M	Sell	73,195 -8	-0%	-$427	0.44%	52
2019 Q4	$4.3M	Sell	73,203 -3,064	-4%	-$170K	0.37%	68
2019 Q3	$4.07M	Sell	76,267 -4,020	-5%	-$207K	0.38%	68
2019 Q2	$4.02M	Buy	80,287 +252	+0.3%	+$12.6K	0.35%	72
2019 Q1	$4.18M	Buy	80,035 +18	+0%	+$899	0.37%	67
2018 Q4	$3.82M	Buy	80,017 +2,932	+4%	+$144K	0.41%	64
2018 Q3	$3.87M	Hold	77,085	–	–	0.32%	67
2018 Q2	$3.88M	Buy	77,085 +160	+0.2%	+$8.06K	0.35%	69
2018 Q1	$3.76M	Buy	76,925 +3,488	+5%	+$162K	0.31%	71
2017 Q4	$3.26M	Sell	73,437 -3,837	-5%	-$177K	0.26%	73
2017 Q3	$3.92M	Buy	77,274 +6,228	+9%	+$316K	0.32%	70
2017 Q2	$3.83M	Buy	71,046 +671	+1%	+$35.8K	0.33%	70
2017 Q1	$3.71M	Buy	70,375 +12,390	+21%	+$629K	0.3%	72
2016 Q4	$2.79M	Sell	57,985 -19,827	-25%	-$979K	0.22%	85
2016 Q3	$4.2M	Buy	77,812 +16,148	+26%	+$885K	0.36%	62
2016 Q2	$3.34M	Sell	61,664 -3,240	-5%	-$171K	0.29%	69
2016 Q1	$3.29M	Buy	64,904 +2,320	+4%	+$116K	0.28%	61
2015 Q4	$3.16M	Hold	62,584	–	–	0.27%	62
2015 Q3	$3.01M	Buy	62,584 +60,622	+3,090%	+$3.16M	0.27%	67
2015 Q2	$58.9K	Sell	1,962 -36,962	-95%	-$2.08M	0.22%	78
2015 Q1	$2.25M	Buy	+38,924	New	+$2.23M	0.17%	83

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Philadelphia Trust Company's GSK Position: Q1 2026 in Review

Philadelphia Trust Company held its GSK (GSK) position steady in Q1 2026 at 53,688 shares worth $2.96M. The position accounts for 0.21% of the portfolio, ranked #71.

Philadelphia Trust Company first reported a position in GSK in Q1 2015 and has held it in 44 quarters since. The position peaked at $4.3M in Q4 2019. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Philadelphia Trust Company held 53,688 shares of GSK worth $2.96M as of Q1 2026.
Philadelphia Trust Company left its GSK share count unchanged in Q1 2026.
GSK made up 0.21% of Philadelphia Trust Company's portfolio in Q1 2026, its #71 holding.
Philadelphia Trust Company first reported a position in GSK in Q1 2015 and has held it in 44 quarters since.
Philadelphia Trust Company's GSK position peaked at $4.3M in Q4 2019.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.